Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial
Convert vial amount to micrograms (if needed): mg 1,000 = mcg Concentration: total amount (mcg) total liquid (mL) = mcg/mL Draw volume: target amount (mcg) concentration (mcg/mL) = mL U100 units: mL 100 = syringe units Worked example (math only) If a vial is labelled 50 mg (50,000 mcg) and you add 10 mL, the concentration is 5,000 mcg/mL
Ottaviani G, Jaffe N
Sick-building syndrome
consistent ~12-15% weight loss at 68 weeks Compound Tirzepatide (Zepbound) Class GIP/GLP-1 dual agonist FDA Status FDA-approved for chronic weight management Evidence Strength Phase 3 RCTs
US$ 27.40
US$ 29.26
US$ 29.08
